Survival impact of concurrent chemoradiotherapy for elderly patients with synchronous oligometastatic esophageal squamous cell carcinoma: A propensity score matching and landmark analyses

被引:11
|
作者
Shi, Zhenguo [1 ,2 ]
Zhu, Xiaojuan [2 ]
Ke, Shaobo [1 ]
Qiu, Hu [1 ]
Cai, Gaoke [1 ]
Zhangcai, Yutian [1 ]
Chen, Yongshun [1 ]
机构
[1] Wuhan Univ, Dept Clin Oncol, Renmin Hosp, Wuhan, Peoples R China
[2] Henan Univ Sci & Technol, Dept Oncol, Affiliated Hosp 1, Luoyang, Peoples R China
基金
中国国家自然科学基金;
关键词
Elderly patients; Synchronous oligometastatic esophageal; squamous cell carcinoma; Concurrent chemoradiotherapy; Survival; Nomogram; CLINICOPATHOLOGICAL CHARACTERISTICS; NEOADJUVANT CHEMORADIOTHERAPY; RADIATION-THERAPY; CANCER; RADIOTHERAPY; ONCOLOGY; CHEMOTHERAPY; MANAGEMENT; OUTCOMES; DISEASE;
D O I
10.1016/j.radonc.2021.09.033
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To evaluate the potential benefits of concurrent chemoradiotherapy (CCRT), and to establish a nomogram for predicting survival outcomes of elderly patients with synchronous oligometastatic esophageal squamous cell carcinoma (SOEC). Materials and methods: This study eventually enrolled 314 elderly patients who initially diagnosed with SOEC from two centers. Treatment responses and outcomes of 151 patients receiving CCRT and 163 patients undergoing chemotherapy alone (CT) were compared. Propensity score matching and landmark analyses were performed to control potential confounding factors. A nomogram was established on the basis of the Cox regression model. Results: After a median follow-up of 42.3 months, CCRT was superior to CT alone in objective response rate (ORR, 59.6% vs. 39.9%, P < 0.001), median progression-free survival (PFS, 10.0 vs. 7.2 months, P < 0.001), and median overall survival (OS, 18.5 vs. 15.6 months, P < 0.001). The propensity score matching (PSM) and landmark analyses redemonstrated the same trend (P < 0.01). On hierarchical analysis, patients with 1- 3 metastatic lesions involving one organ displayed longer median PFS (9.0 vs. 7.8 months, P = 0.008) and OS (17.8 vs. 15.2 months, P < 0.001) than those with 4-5 metastatic lesions involving 2-3 organs. The major toxicities of grade III or higher for CCRT included leukocytopenia (23.2%), radiation esophagitis (7.3%), and radiation pneumonitis (8.6%). Cox multivariate analysis showed that the number of metastatic lesions (P = 0.012) and tumor response (P < 0.001) were independent prognostic factors associated with OS. A nomogram was established by incorporating the number of metastatic lesions and tumor response, with a concordance index of 0.743 after internal cross-validation. Calibration curves and decision curve analysis confirmed that nomogram had a favorable predictive value for individualized survival. Conclusions: Compared with CT alone, CCRT exhibited superior efficacy and acceptable toxicity in the first line treatment for elderly patients with SOEC. The current study supports the oligometastatic definition of <3 metastatic lesions involving one organ for esophageal cancer patients. The constructed nomogram can effectively predict the individualized survival. (c) 2021 Elsevier B.V. All rights reserved. Radiotherapy and Oncology 164 (2021) 236-244
引用
收藏
页码:236 / 244
页数:9
相关论文
共 50 条
  • [41] Radiotherapy Alone or Concurrent Chemoradiation for Esophageal Squamous Cell Carcinoma in Elderly Patients
    Zhao, L.
    Zhou, Y. C.
    Pan, H.
    Yin, Y.
    Lin, S. H.
    Shi, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E205 - E206
  • [42] Impact of Radiation Dose on Survival for Esophageal Squamous Cell Carcinoma Treated With Neoadjuvant Chemoradiotherapy
    Yang, Yang
    Xu, Xiaofang
    Zhou, Xia
    Bao, Wuan
    Zhang, Danhong
    Gu, Feiying
    Du, Xianghui
    Chen, Qixun
    Qiu, Guoqin
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [43] Neck Lymph Node Metastasis as A Poor Prognostic Factor in Thoracic Esophageal Squamous Cell Carcinoma Patients Receiving Concurrent Chemoradiotherapy: A Propensity Score-Matched Analysis
    Chen, Yen-Hao
    Lu, Hung-, I
    Lo, Chien-Ming
    Wang, Yu-Ming
    Chou, Shang-Yu
    Hsiao, Chang-Chun
    Shih, Li-Hsueh
    Chen, Su-Wei
    Li, Shau-Hsuan
    SCIENTIFIC REPORTS, 2018, 8
  • [44] Clinical predictors of survival for elderly patients with esophageal squamous cell carcinoma
    Lai, Kuan-Ming
    Tsai, Chien-Yu
    Yan, Sheng-Lei
    ADVANCES IN DIGESTIVE MEDICINE, 2025, 12 (01)
  • [45] Concurrent chemoradiotherapy versus radiotherapy alone for patients with locally advanced esophageal squamous cell carcinoma in the era of intensity modulated radiotherapy: a propensity score-matched analysis
    Li, Chen
    Tan, Lijun
    Liu, Xiao
    Wang, Xin
    Zhou, Zongmei
    Chen, Dongfu
    Feng, Qinfu
    Liang, Jun
    Lv, Jima
    Wang, Xiaozhen
    Bi, Nan
    Deng, Lei
    Wang, Wenqing
    Zhang, Tao
    Ni, Wenjie
    Chang, Xiao
    Han, Weiming
    Gao, Linrui
    Wang, Shijia
    Xiao, Zefen
    THORACIC CANCER, 2021, 12 (12) : 1831 - 1840
  • [46] Neck Lymph Node Metastasis as A Poor Prognostic Factor in Thoracic Esophageal Squamous Cell Carcinoma Patients Receiving Concurrent Chemoradiotherapy: A Propensity Score-Matched Analysis
    Yen-Hao Chen
    Hung-I Lu
    Chien-Ming Lo
    Yu-Ming Wang
    Shang-Yu Chou
    Chang-Chun Hsiao
    Li-Hsueh Shih
    Su-Wei Chen
    Shau-Hsuan Li
    Scientific Reports, 8
  • [47] Correspondence: Statin Use During Concurrent Chemoradiotherapy With Improved Survival Outcomes in Esophageal Squamous Cell Carcinoma
    Chen, Wan-Ming
    Yu, Ying-Hui
    Chen, Mingchih
    Shia, Ben-Chang
    Wu, Szu-Yuan
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (10) : E106 - E108
  • [48] Synchronous esophageal cancer impact on survival of head and neck squamous cell carcinoma (HNSCC) patients.
    Amor Divino, Paulo Henrique
    Ramos Matos, Gustavo Duarte
    Lima, Karolina
    Castro, Gilberto
    Marta, Gustavo Nader
    Takeda, Flavio Roberto
    Cecconello, Ivan
    Melro Braghiroli, Oddone Freitas
    Mak, Milena Perez
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [49] Concurrent Erlotinib and Radiotherapy for Chemotherapy-intolerant Esophageal Squamous Cell Carcinoma Patients: A Propensity Score-Matched Analysis
    Zhai, Y. R.
    Hui, Z.
    Men, Y.
    Liang, J.
    Wang, J.
    Feng, Q.
    Zhou, Z.
    Xiao, Z.
    Bi, N.
    Wang, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E206 - E206
  • [50] Prognostic impact of eosinophils in peripheral blood and tumor site in patients with esophageal squamous cell carcinoma treated with concurrent chemoradiotherapy
    Yang, Xiyue
    Wang, Lei
    Du, Huan
    Lin, Binwei
    Yi, Jie
    Wen, Xuemei
    Geng, Lidan
    Du, Xiaobo
    MEDICINE, 2021, 100 (03) : E24328